INVO Bioscience, Inc. (IVOB) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated August 14, 2019, reports on INVO Bioscience, Inc. (IVOB), a Nevada corporation headquartered in Sarasota, Florida. The filing serves to disclose the Company's financial results for the quarterly period ended June 30, 2019, via a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the issuance of results for the quarter ended June 30, 2019.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated. No specific guidance, outlook, or risk factors are detailed in the text of this 8-K form itself.
Investor Verification Checklist
- Verify the specific revenue and net loss figures in the attached press release (Exhibit 99.1).
- Confirm the Company's cash position and runway based on the full quarterly report.
- Review the press release for any updates on clinical trial progress or regulatory milestones.
- Check for any new debt obligations or equity financing activities mentioned in the full disclosure.